INTEGRA LIFESCIENCES HOLDINGS CORP Available-for-sale Securities, Gross Realized Gain (Loss)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2020-02-21
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for the quarter ending 2018-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for the quarter ending 2018-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for fiscal 2019 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for fiscal 2018 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for fiscal 2017 was -$2.29M.
- INTEGRA LIFESCIENCES HOLDINGS CORP available-for-sale securities, gross realized gain (loss) for fiscal 2016 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-21 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | $0.00 10-K · filed 2020-02-21 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-26 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | -$2.30M derived: sum of 3 quarters · filed 2020-02-21 | -$2.29M 10-K · filed 2020-02-21 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$2.30M derived: sum of 2 quarters · filed 2018-11-01 | -$2.29M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | -$2.30M 10-Q · filed 2018-11-01 | -$2.29M 10-Q · filed 2018-07-26 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |